Related Experiment Video
Updated: Feb 24, 2026

Technique and Patient Selection Criteria of Right Anterior Mini-Thoracotomy for Minimal Access Aortic Valve Replacement
Published on: March 26, 2018
Preoperative Aspirin Does Not Increase Transfusion or Reoperation in Isolated Valve Surgery
Jordan E Goldhammer1, Corey R Herman1, Mark W Berguson1
1Department of Anesthesiology, Sidney Kimmel Medical College at Thomas Jefferson University Hospital, Philadelphia, PA.
Insights
Preoperative aspirin use in elective heart valve surgery did not increase bleeding or transfusion rates. This study found no significant difference in major adverse events or mortality for patients taking aspirin before surgery.
Area of Science:
- Cardiology
- Cardiac Surgery
- Pharmacology
Background:
- Preoperative aspirin use is common in cardiac surgery patients.
- Limited data exists on aspirin's impact in valve surgery compared to coronary artery bypass graft surgery.
Purpose of the Study:
- To investigate the effects of preoperative aspirin on bleeding and transfusion requirements in patients undergoing elective, isolated heart valve repair or replacement.
Main Methods:
- Retrospective cohort study of 488 patients undergoing non-emergent, isolated valve surgery.
- Patients were divided into two groups: those taking aspirin preoperatively (n=282) and those not (n=206).
- Logistic regression analysis was used to compare outcomes between groups.
Main Results:
- No significant differences were observed in red blood cell (RBC) transfusion rates, mean RBC units transfused, or massive transfusion requirements.
- Aspirin use was not associated with an increased rate of re-exploration for bleeding (5.3% vs. 6.3%, p=0.478).
- Major adverse cardiocerebral events (MACE), 30-day mortality, and 30-day readmission rates were similar between groups.
Conclusions:
- Preoperative aspirin therapy in elective, isolated valve surgery does not increase transfusion or reoperation for bleeding.
- Aspirin therapy was not associated with reduced readmission rates, MACE, or 30-day mortality in this patient population.
Objective:
Preoperative aspirin has been studied in patients undergoing isolated coronary artery bypass graft surgery. However, there is a paucity of clinical data available evaluating perioperative aspirin in other cardiac surgical procedures. This study was designed to investigate the effects of aspirin on bleeding and transfusion in patients undergoing non-emergent, isolated, heart valve repair or replacement.
Design:
Retrospective, cohort study.
Setting:
Academic medical center.
Participants:
A total of 694 consecutive patients having non-emergent, isolated, valve repair or replacement surgery at an academic medical center were identified.
Interventions:
Of the 488 patients who met inclusion criteria, 2 groups were defined based on their preoperative use of aspirin: those taking (n = 282), and those not taking (n = 206) aspirin within 5 days of surgery.
Measurements And Main Results:
Binary logistic regression was used to examine relationships among demographic and clinical variables. No significant difference was found between the aspirin and non-aspirin groups with respect to the percentage receiving red blood cell (RBC) transfusion, mean RBC units transfused in those who required transfusion, massive transfusion of RBC, or amounts of fresh frozen plasma, cryoprecipitate, or platelets. Aspirin was not associated with an increase in the rate of re-exploration for bleeding (5.3% v 6.3%, p = 0.478). Major adverse cardiocerebral events (MACE), 30-day mortality, and 30-day readmission rates were not statistically different between the aspirin-and non-aspirin-treated groups.
Conclusions:
Preoperative aspirin therapy in elective, isolated, valve surgery did not result in an increase in transfusion or reoperation for bleeding and was not associated with reduced readmission rate, MACE, or 30-day mortality.
Related Concept Videos
Aneurysm IV: Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Venous Thrombosis III: Interprofessional Care
Mitral Stenosis III: Medical Management

